Medical AI

The company's new AI platform isn't another app to juggle. It's an intelligent layer over existing systems, a strategic bet on augmenting, not replacing, clinicians.

Venture builder Foresite Labs hires AstraZeneca's AI leader, Dr. Jorge Reis-Filho, in a strategic move that signals a new era for AI-driven company creation.

A Breakthrough T1D grant for Greenstone Bio isn't just funding; it's a major signal validating a new R&D paradigm using AI and bio-digital twins.

A simple urine test could soon detect cancer early. With $33M in fresh funding, Japanese bio-AI firm Craif is betting its tech can change U.S. healthcare.

An AI tool just received FDA clearance to quantify Alzheimer's biomarkers in brain scans. It promises earlier answers, but raises profound questions for patients and our healthcare system.

20/20 BioLabs' record revenue is just the surface. Underneath, the company is building an AI-powered health network, starting with firefighters and cities.

A new AI platform from n1.care aims to turn years of scattered medical files into one clear picture, promising to save doctors time and improve diagnoses.

Intermountain Health becomes the first to deploy an FDA-approved AI, aiming to eliminate the dreaded second surgery for thousands of breast cancer patients.

Landing on the Inc. 5000 is just the headline. The real story is how iScribeHealth's ambient AI is tackling healthcare's $43B paperwork crisis.

The FDA is betting on AI to manage chronic illness. Cadence's new pilot for its hypertension software could rewrite the rules for digital health regulation.

A new study shows 98% success for Mendaera's handheld robot. Beyond the launch, can this device truly bridge the gap in specialized medical skills?

Beyond finance, Ant Group is building a vast AI healthcare ecosystem. Its new AQ for Doctor platform isn't just a tool—it's a strategic move to wire together patients, physicians, and hospitals, with major implications for China's medical landscape.

SimX's new Autonomous Simulation uses VR and a 'walled-garden' AI to let medical students practice anytime, anywhere, aiming to solve a critical training bottleneck.

With FDA clearance for its AI burn scanner, Spectral AI faces its next test: conquering the market. Can it turn government contracts into commercial success?

NeuroPace reports strong Q2 growth and raises 2026 guidance, driven by its RNS system. A new AI tool and key clinical data signal a deeper push into personalized medicine.

A new report reveals how Knowtex's AI is saving VA doctors hours of paperwork, boosting patient trust, and setting a new standard for federal healthcare.

OTraces' new AI analyzes biological 'noise' to forecast Type 1 Diabetes with over 92% accuracy, promising a new era of early intervention and care.

Qventus's AI suite adds $17.1M in revenue by proactively treating patients, proving automation is no longer hype but a critical lifeline for modern healthcare.

A new platform offers physicians 24/7 access to 'lifelike' AI pharma reps. We analyze the tech, the immense regulatory risks, and the potential to level the playing field.

Mercyhealth's new partnership with Vitea reveals a critical shift: to unlock AI's potential, health systems must first tame its risks with strategic governance.